DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Interaction of Statins and Nondepolarizing Muscle Relaxants

Information source: First Hospital of China Medical University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pain

Intervention: Rocuronium (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Huang-wei LV

Official(s) and/or principal investigator(s):
Huangwei Lv, Professor, Study Director, Affiliation: the Anesthesiology Department


provide evidence for prevention or reduction muscle pain.

Clinical Details

Official title: Interaction of Statins and Nondepolarizing Muscle Relaxants

Study design: Observational Model: Case Control, Time Perspective: Prospective

Primary outcome: plasma myoglobin concentration

Secondary outcome:

muscle pain

serum potassium concentration

plasma creatine phosphokinase concentration

urine myoglobin and onset plus duration of succinylcholine block

Detailed description: The purpose of this study is to determine interaction of statins and nondepolarizing muscle relaxant,In order to provide evidence for prevention or reduction muscle pain.


Minimum age: 40 Years. Maximum age: 80 Years. Gender(s): Both.


Inclusion Criteria:

- Patients with American Society of Anesthesiologists physical status I-III

- Patients taking statins for at least 3 months and those who had never used statins

were considered to be eligible Exclusion Criteria:

- Orthopedic

- Spinal surgery

- Surgery involving extensive muscle manipulation

- History of liver and kidney failure

- Neuromuscular disease

- Susceptibility to or family history of malignant hyperthermia

- Extensive denervation of skeletal muscle

- Chronic pain syndromes

- Taking medications that might interact with the effect of rocuronium or serum

myoglobin difficult intubation

Locations and Contacts

China Medical University, Shenyang, Liaoning 110001, China; Recruiting
Huang-wei Lv, Professor, Phone: 86-024-83283100, Email: hwl1998@yahoo.com
Huang-wei LV, Professor, Principal Investigator
Additional Information

Starting date: October 2014
Last updated: October 22, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017